Overview Study in Patients With COPD Status: Completed Trial end date: 2006-04-01 Target enrollment: Participant gender: Summary The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo. Phase: Phase 3 Details Lead Sponsor: DeyTreatments: Formoterol Fumarate